- Chronic low magnesium levels, confirmed by two blood tests within a year, were associated with a 74% higher risk of nontraumatic intracranial hemorrhage.
- The risk was even greater—roughly double—for those with severely low magnesium levels below 1.5 mg/dL.
- Researchers analyzed medical records of over 266,000 matched patient pairs from the TriNetX Global Collaborative Network.
- While relative risk was substantial, absolute numbers remained small: 0.52% of low-magnesium patients experienced brain bleeds versus 0.31% in the normal group.
- The study suggests magnesium's role in blood vessel function and blood pressure regulation may explain the connection.
A silent risk factor emerges
Millions of Americans with chronically low magnesium levels face a significantly elevated risk of bleeding in the brain, according to a large retrospective study published in Frontiers in Nutrition.
The research, which tracked more than half a million adults over five years, found that individuals with two low serum magnesium readings within a single year had a 74% higher risk of nontraumatic intracranial hemorrhage—bleeding in or around the brain not caused by injury. The findings add to growing evidence that magnesium, often overlooked in routine medical care, plays a critical role in vascular health.
The study's design and scope
Researchers used the TriNetX Global Collaborative Network, analyzing medical records from 2010 through 2024. They identified 266,133 adults whose blood tests showed magnesium levels below 1.7 mg/dL twice within a year—a threshold that helps rule out temporary dips. Each was matched with a comparable individual with normal magnesium levels, accounting for age, sex, existing conditions, medications and other laboratory markers.
The study excluded anyone with prior strokes, brain bleeds, advanced kidney disease, dialysis, or recent serious illness. Over the follow-up period, investigators tracked incident hemorrhagic events, all-cause mortality and severe blood pressure elevations.
A dose-response relationship
The association followed a clear pattern: the lower the magnesium, the higher the risk. Individuals with severely low levels—below 1.5 mg/dL—showed approximately double the risk of brain bleeding compared to those with normal levels.
"We found a stronger association with severe low magnesium levels, suggesting an exposure-gradient relationship," the authors wrote. The connection appeared consistent across men and women, as well as adults under and over 65.
Beyond brain bleeds, low magnesium status correlated with increased risks of intracerebral hemorrhage, subarachnoid hemorrhage and all-cause mortality. The hazard ratio for all-cause mortality stood at 1.49, indicating a 49% higher risk of death from any cause among the low-magnesium group.
Why magnesium matters for brain health
Magnesium helps blood vessels relax, supports the lining of vessel walls and participates in blood clotting mechanisms. Prior research has established that higher magnesium intake is associated with lower risk of ischemic stroke—the more common type caused by blocked vessels. However, evidence linking magnesium to hemorrhagic stroke has been more difficult to establish.
A 2021 Mendelian randomization study published in Neurology found that genetically predicted higher serum magnesium concentrations were associated with reduced risk of intracranial aneurysm and aneurysmal subarachnoid hemorrhage. That research suggested magnesium's protective effects may operate partly through blood pressure regulation and improvements in endothelial function.
The current study found that the gap in brain bleed risk narrowed when researchers adjusted for clotting, iron and electrolyte abnormalities—conditions that often accompany low magnesium and independently raise bleeding risk. This suggests low magnesium may serve as both a contributing factor and a marker of overall illness burden.
Interpreting the findings
Bleeding events remained rare in both study groups, with absolute rates of 0.52% in the low-magnesium group and 0.31% in the control group. The 74% relative risk increase translates to a difference between two relatively small numbers.
The study's observational design cannot establish causation or clarify whether low magnesium directly contributes to bleeding risk or simply indicates underlying health problems. Notably, an exploratory analysis found that magnesium levels above the normal range were also associated with higher bleeding risk, suggesting that more is not necessarily better.
"Records-based research can spot the pattern without establishing the order of events," the study noted.
Practical implications
For individuals whose magnesium levels consistently test low, the findings warrant discussion with a healthcare provider. Low intake, absorption issues, kidney handling of the mineral and common medications—including diuretics and acid reducers—can all contribute to deficiency.
Magnesium-rich foods include leafy greens, beans, lentils, nuts, seeds and whole grains. Organic salts of magnesium, including glycinate and taurinate forms, offer better bioavailability than mineral salts such as magnesium oxide.
The Institute of Medicine sets the upper tolerable limit for supplemental magnesium at 350 mg of elemental magnesium per day for individuals with normal kidney function.
A call for clinical attention
This research adds to a growing body of evidence linking magnesium status to serious health outcomes, including cardiovascular disease, metabolic syndrome and neurological disorders. Previous studies have shown that roughly half of the U.S. population consumes less than the recommended amount of magnesium.
The study authors emphasized that their findings warrant confirmation through prospective research to determine whether magnesium represents a modifiable risk factor. For now, the message is clear: persistently low magnesium readings deserve attention, not dismissal.
Given magnesium's essential role in vascular function and the public health implications of widespread deficiency, clinicians may consider closer monitoring of this often-overlooked laboratory value, particularly in patients with cardiovascular risk factors.
Sources for this article include:
Please contact us for more information.